Tempest Therapeutics, Inc.

TPST ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $17.6M $43.9M $43.2M $6.4M $18.1M $14.8M $4.5M
Accounts Receivable
Inventory
Total Current Assets $19.7M $116.4M $129.9M $61.9M $45.1M $32.0M $4.6M
Property, Plant & Equipment $3.1M $5.6M $8.3M $3.4M $880.0K $756.0K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $19.8M $122.5M $138.6M $65.6M $47.5M $32.8M $4.6M
Liabilities
Accounts Payable $1.3M $2.2M $3.4M $2.5M $1.7M $875.0K $276.0K
Total Current Liabilities $4.1M $13.2M $11.2M $10.2M $5.8M $2.1M $675.0K
Long-Term Debt $599.0K
Total Liabilities $4.8M $14.3M $11.8M $10.2M $5.8M $2.1M $762.0K
Stockholders' Equity
Retained Earnings $-136.9M $-250.2M $-167.9M $-94.7M $-45.2M $-16.1M $-2.6M
Total Stockholders' Equity $-130.7M $108.2M $126.9M $55.3M $41.7M $30.7M $-2.4M
← Newer Page 2 of 2 Older →